Frontlight ResearchEarly access
What researchers published on Triple-negative breast cancer
19,695 papers, newest first.
Showing 180 of 19,695
RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy.PloS one
Phase-Space Distance Between Stationary States Modulates Phenotypic Plasticity in Breast Cancer.Bulletin of mathematical biology
Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer.Biomaterials science
Case reportPembrolizumab-Associated Secondary Adrenal Insufficiency Due to Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Presenting as Recurrent Multisystem Decompensation in Triple-Negative Breast Cancer.Cureus
Tertiary lymphoid structures and the systemic immune-inflammation index define distinct pathologic response phenotypes in triple-negative breast cancer receiving neoadjuvant chemoimmunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
MRI Radiomics-Based Nomogram Integrating Skeletal Muscle Assessment for Predicting Pathologic Complete Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Diagnostics (Basel, Switzerland)
β-galactosidase-activatable photosensitization for selective, light-amplified pyroptosis therapy of triple-negative breast Cancer cells.Bioorganic chemistry
In Vitro Models of Triple-Negative Breast Cancer of Sub-Saharan African Ancestry Suggest BLM-Centred DNA Damage Repair Dependency and Pevonedistat Sensitivity.International journal of molecular sciences
ReviewThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
Leptin-Driven Distinct Transcriptional Reprogramming in Triple-Negative Breast Cancer: Implications for Racial Disparities.International journal of molecular sciences
Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients.Frontiers in oncology
Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation.Journal of clinical medicine
ReviewRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
RETRACTED: Kim et al. Autocrine Motility Factor and Its Peptide Derivative Inhibit Triple-Negative Breast Cancer by Regulating Wound Repair, Survival, and Drug Efflux. Int. J. Mol. Sci. 2024, 25, 11714.International journal of molecular sciences
Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.International journal of clinical oncology
ReviewSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.Tissue & cell
Matrix-Associated Gene Expression and Annotated Tumor-Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer.Cancers
Oral 25-Hydroxycholesterol Suppresses 4T1 Tumour Growth in an Immune-Context-Associated Manner.International journal of molecular sciences
Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study.Cancers
ReviewCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer.Current cancer drug targets
CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings.Journal of immunology (Baltimore, Md. : 1950)
Dual-Targeted Nanoparticle Chimeras Induce Bioenergetic Crisis by Coupling Lipid Droplet Degradation with Nicotinamide Adenine Dinucleotide Reduction in Triple-Negative Breast Cancer.Acta biomaterialia
Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor.Pharmacological research
FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study.PloS one
Beyond resveratrol: Vitis vinifera grape cane extracts selectively induce apoptosis in glioblastoma and triple-negative breast cancer cells via Bcl-2/Bax/Caspase-3 pathway.Fitoterapia
HOXC12 Expression in Triple-negative Breast Cancer: Clinicopathological Correlations and Potential as a Prognostic Biomarker.Current drug targets
ReviewThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer.The oncologist
Correction: Eustace et al. TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. Cancers 2025, 17, 1614.Cancers
Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada.American journal of clinical oncology
Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.Breast (Edinburgh, Scotland)
SIMMPYRA1 and SIMMPYRA2 suppress triple-negative breast cancer growth through selective STAT3 inhibition.Cell chemical biology
Relevance of toll-like receptor-4 in the pathogenesis of triple negative breast cancer.Molecular biology reports
CDK4/6-Mediated Growth Arrest Enhances Cell Stiffness and Contractility in RB-Proficient Triple-Negative Breast Cancer Cells in 3D Hydrogels.Tissue engineering. Part A
RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis.Experimental hematology & oncology
Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors.Neoplasia (New York, N.Y.)
Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
ReviewGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
Meta-analysisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine
CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Bifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer.Advanced pharmaceutical bulletin
Egonol restores tamoxifen sensitivity via the miR-3529-5p-CLOCK axis in triple-negative breast cancer cells.Fitoterapia
Effect of Exosome-loaded hsa-miR-203a-3p on Triple Negative Breast Cancer Cell Viability, Migration, and Gene Targets: In Silico and In Vitro Study.Advanced pharmaceutical bulletin
CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer.Journal of inflammation research
CircEML1 upregulates BTG2 to suppress the progression of triple-negative breast cancer.Biology direct
Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde.Biomacromolecules
Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.Signal transduction and targeted therapy
Decoding neutrophil spatial heterogeneity and clinical implications in breast cancer.Cancer cell
Geographical access to radiotherapy and surgical treatment selection in older women with HER2-positive and triple-negative breast cancer: A real-world exploratory study.Journal of geriatric oncology
Durable Treatment-Free Remission in BRCA1-Associated Metastatic Triple-Negative Breast Cancer with Brain and Radiologically Diagnosed Hepatic Metastases: A Case Report.Oncology and therapy
ReviewBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
Neutrophils are known by their neighbors in breast cancer.Cancer cell
Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.International journal of biological macromolecules
Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).BMC medicine
PreprintSpatial context of cellular heterogeneity in triple-negative breast cancer reveals actionable subtypes.bioRxiv : the preprint server for biology
PreprintReprogramming CAR-T cell function through synthetic cytokine receptors suppresses metastatic progression of TNBC.bioRxiv : the preprint server for biology
IMPACT: Investigating Metaplastic Breast Cancer Prognosis against Conventional Triple-Negative Invasive Ductal Carcinoma.Indian journal of surgical oncology
PreprintTamoxifen and Doxorubicin Synergistically Target Estrogen Receptor β-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer.bioRxiv : the preprint server for biology
Therapeutic value of PD-1/PD-L1 blockade plus chemotherapy in advanced or metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials.Translational cancer research
Case reportCase Report: Unicentric Castleman disease mimicking metastatic lymphadenopathy in a patient with a history of triple-negative breast cancer and angiomatoid fibrous histiocytoma.Frontiers in oncology
Uncovering the immune microenvironmental atlas of breast cancer molecular subtypes based on single-cell transcriptomics.PloS one
ReviewAdvanced platinum strategies for triple-negative breast cancer.Trends in pharmacological sciences
Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial.Translational breast cancer research : a journal focusing on translational research in breast cancer
PreprintAndrogen receptor expression is associated with a distinct low-proliferative phenotype in triple-negative breast cancer.Research square
Benefits and adverse events of combined chemotherapy and immune checkpoint inhibition in non-metastatic triple-negative breast cancer: a systematic review and an updated meta-analysis.Translational breast cancer research : a journal focusing on translational research in breast cancer
TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC.Materials today. Bio
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.Drug development research
Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.Molecular biology reports
O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability.Biochimica et biophysica acta. Molecular basis of disease
Real-World Toxicity and Outcomes of KEYNOTE-522-Style Neoadjuvant Pembrolizumab for Triple-Negative Breast Cancer in Australia.Asia-Pacific journal of clinical oncology
PreprintResponse to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation.bioRxiv : the preprint server for biology
LARP1-mediated stabilization of CD73 mRNA promotes immune escape in triple-negative breast cancer.Frontiers in immunology
Identification of SLC7A5 and transferrin as key ferroptosis modulators in triple-negative breast cancer.Oncology letters
Evaluating Physician Perspectives on Neoadjuvant Immunotherapy and Chemotherapy for Early-Stage Triple-Negative Breast Cancer.Clinical breast cancer
Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials.JCO oncology advances
Case reportCase Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma.Frontiers in oncology
Targeting the ERO1A-PDIA1 redox axis in triple-negative breast cancer with AI-designed minibinders.Cell death discovery
Quercetin Promotes Apoptosis of Triple-Negative Breast Cancer Cells by Inducing Endoplasmic Reticulum Stress and Activating the ATF4/CHOP Pathway.Anti-cancer agents in medicinal chemistry
Biochanin A Induces Cuproptosis and Inhibits Lung Metastasis in triple-negative Breast Cancer.Oncology research
RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway.Oncogene
TFAP2A promotes the stemness and metastasis of luminal B/HER2-positive and triple-negative breast cancer cells by enhancing KDM4B transcriptional activity.Molecular biology reports
Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer.Frontiers in pharmacology
SAGE1-Mediated H3K27ac Enrichment Promotes Chromatin Opening and Fanconi Anemia Repair to Induce Carboplatin Resistance in Triple-Negative Breast Cancer.Cancer letters
One size does not fit all: the inclusion of carboplatin in neoadjuvant treatment of triple-negative breast cancer.Chinese clinical oncology
Activity and safety of first-line pumitamig plus nab-paclitaxel in triple-negative breast cancer: a single-arm, phase 1b/2 trial.The Lancet. Oncology
STEAP3 Modulates Macrophage Polarization in TNBC by Promoting Nuclear Transport of ERK5.The Tohoku journal of experimental medicine
Novel aptamer-based strategies for addressing aggressive and heterogeneous triple-negative breast cancer.Frontiers in oncology
Trial resultEribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial.Frontiers in immunology
Trophoblast cell-surface antigen 2-directed enhancement of gene delivery using a nanobody-engineered recombinant adeno-associated virus for bispecific T-cell engager-mediated T-cell cytotoxicity in triple-negative breast cancer cells.International journal of biological macromolecules
Predicting neoadjuvant chemotherapy efficacy in triple-negative breast cancer using DCE-MRI and mammographic texture.Breast cancer (Tokyo, Japan)
Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53-MDM2 Inhibitors for Triple-Negative Breast Cancer.Current topics in medicinal chemistry
Dual-organelle-coordinated sonodynamic nanoplatform amplifies immunogenic cell death to drive robust antitumor immunity in cold tumors.Journal of nanobiotechnology
ReviewResearch progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer.Frontiers in molecular biosciences
A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer.Acta pharmaceutica Sinica. B
Event-free survival in patients with early triple-negative breast cancer receiving platinum-free, de-escalated anti-PD-1 neoadjuvant therapy: an updated analysis of the NeoTENNIS trial.Cancer letters
Novel therapies create potential new options for patients with advanced breast cancer: First-line sacituzumab govitecan plus pembrolizumab may improve long-term outcomes for patients with advanced triple-negative breast cancer, whereas the new CDK4/6 inhibitor fovinaciclib shows promising efficacy.Cancer
ReviewResidual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy-Pembrolizumab Integration.Cancer management and research
Characterization of cancer stem-like cells derived from a single 4T1 murine triple-negative breast cancer cell: Involvement of Akt‒mTOR pathway in the proliferation and sphere formation.Archives of biochemistry and biophysics
Spatially resolved GR-TGFβ co-activation underlies cell-type-specific signalling in triple-negative breast cancer.Cell communication and signaling : CCS
Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer.ESMO open
Novel 68Ga-labeled peptide for SORT1-targeted PET imaging: development and preclinical validation in triple-negative breast cancer.Bioorganic chemistry
Early temporal transcriptional and cytokine responses distinguish chemotherapy sensitivity in patient-derived xenograft models of triple-negative breast cancer.Oncogene
BBR-RHE Co-Loaded Nanoemulsion Potentiates Anti-PD-L1 Efficacy via Lipid Metabolic Reprogramming in Triple-Negative Breast Cancer.Molecular pharmaceutics
Nanocatalytic Immunotherapy Targeting Tumor-Resident Intracellular Bacteria for Triple-Negative Breast Cancer Treatment and Metastasis Suppression.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
An Asp49 phospholipase A2 from Bothrops pictus impairs triple-negative breast cancer cell proliferation, migration, and promotes stromal inflammatory responses with altered integrin expression.International journal of biological macromolecules
Non-invasive electromagnetic fields induce anti-tumor neutrophil reprogramming and enhance checkpoint blockade in breast cancer.Frontiers in immunology
High LAT1 Expression Is Associated With CD163+ Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer.Cancer genomics & proteomics
Correction: Advancements in polymer-based drug delivery systems targeting the tumor microenvironment for immunotherapy of triple-negative breast cancer.Frontiers in immunology
Clinicopathological features, recurrence patterns, and survival outcomes of triple-negative ductal carcinoma in situ: a single-center cohort study.World journal of surgical oncology
Context-dependent in transcriptional modulation of RhoA/ROCK1 expression under complete vs. deprived serum conditions in TNBC transduced cells.Molecular biology reports
Targeting PRMT5 to reshape the immune microenvironment and reverse Trop2 ADC resistance in triple-negative breast cancer.Cellular oncology (Dordrecht, Netherlands)
A marine-derived sesterterpenoid inhibits migration and invasion of triple-negative breast cancer cells by suppressing the FAK signaling pathway.Frontiers in cell and developmental biology
Constitutive androgen receptor activity sustains DNA replication programs in triple-negative breast cancer.Cell death & disease
Taurine preserves γδ T cell fitness in triple-negative breast cancer.Cell communication and signaling : CCS
Case reportMultifocal FDG-avid pancreatic pseudomasses mimicking metastases during pembrolizumab for axillary recurrence of triple-negative breast cancer: a case report of immune-related pancreatitis.Frontiers in oncology
Luminal B-like predominance in breast cancer: A 5-year institutional experience of 2271 women from a tertiary cancer center in South India.Journal of cancer research and therapeutics
From classical survival statistics to explainable AI: A multi-method prognostic framework for triple negative breast cancer.Journal of cancer research and therapeutics
Mechanisms of pregnancy-associated triple negative breast cancer risk: insights from spatial omics.Cancer research communications
"Chitosan-Carrageenan Nanocarriers Potentiate Anticancer Efficacy of Laxmitaru against Triple-Negative Breast Cancer".Drug development and industrial pharmacy
Trial resultPhase 1 study of OX40 agonist ABBV-368 as monotherapy or in combination with budigalimab in advanced solid tumors.Future oncology (London, England)
In plain wordsRead moreRead the paper on PubMedSociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.Breast cancer research and treatment
Co-targeting ASAH1 and the histone reader BRD1 potently suppresses TNBC growth through the transcriptional repressor BCL6.Oncogenesis
ReviewCancer-associated fibroblasts in triple-negative breast cancer: heterogeneity, tumor-stroma crosstalk, and therapeutic resistance.Frontiers in oncology
Targeting the SMG9-Wnt/β-catenin axis: A novel mechanism by which ginsenoside Rh2 suppresses triple-negative breast cancer progression.Journal of ginseng research
ReviewTargeting triple-negative breast cancer: Molecular basis and emerging antibody-drug conjugate strategies.Biochimica et biophysica acta. Molecular basis of disease
Survival of cancer cells following taxol-induced apoptosis is supported by ZEB1-mediated ferroptosis sensitivity.Cell death & disease
Cisplatin@nZIF-8 nanoparticles enable NIR-assisted drug release and ROS-mediated DNA damage for enhanced chemotherapy against triple-negative breast cancer.Journal of photochemistry and photobiology. B, Biology
Glucose-Dependent Cytotoxic Responses in Triple-Negative Breast Cancer: Experimental and Transcriptomic Evidence of Metabolic Context and p38 MAPK-Associated Modulation.Breast cancer (Dove Medical Press)
Racial and Ethnic Variation in Survival Among Premenopausal Women With Triple Negative Breast Cancer.The Journal of surgical research
Survival Outcomes in Metaplastic Versus Triple-Negative Invasive Breast Carcinoma: A Propensity Score-Matched Study.Medicina (Kaunas, Lithuania)
Predicting Chemotherapy Response in Triple-Negative Breast Cancer: The Role of CYP2Cs as a Biomarker and a Drug Target (A Proof-of-Concept Study).Pharmaceuticals (Basel, Switzerland)
Machine Learning-Guided Virtual Screening Identifies a Novel MELK-Targeted Antiproliferative Lead Compound with G2/M Arrest Activity in Triple-Negative Breast Cancer and Lung Adenocarcinoma Cells.Cancers
Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis.Oncology letters
A Water-Soluble Pro-Drug of Acetaminophen Has Increased Intracellular Delivery of Active Drug and Anti-Cancer Activity in Triple-Negative Breast Cancer and Pancreatic Ductal Adenocarcinoma.Cancers
Anticancer Activity of Novel Epoxyazadiradione AuNp Complex in TNBC Cells.Asian Pacific journal of cancer prevention : APJCP
BRCA1 Promoter Methylation Marks a Shared Blood Methylome State in Women with and Without Breast Cancer.International journal of molecular sciences
Real-World Feasibility, Toxicity, and Early Outcomes of Neoadjuvant Pembrolizumab-Based Systemic Therapy in Early Triple-Negative Breast Cancer: A Single-Centre Chinese Cohort from Hong Kong.Cancers
Claudin 1 promotes blood-borne metastasis by modulating the Src/Ezrin signaling pathway in high-CLDN1 triple-negative breast cancer model.Molecular & cellular oncology
A real-world nomogram integrating predictive markers for disease-free survival in postmenopausal triple-negative breast cancer receiving anthracycline/taxane-based chemotherapy.Frontiers in oncology
Supramolecular self-assembled nanomedicine targeting fatty acid metabolism to potentiate ferroptosis-enhanced photoimmunotherapy in triple-negative breast cancer.Materials today. Bio
Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling.Current issues in molecular biology
ReviewClinical Challenges in Triple-Negative Breast Cancer (TNBC): Current Treatment Options, Their Limitations, and Emerging Perspectives.Cancers
Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer.International journal of molecular sciences
SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancer.Frontiers in immunology
ReviewMorphology-Guided Diagnosis of Triple-Negative Breast Carcinoma: From Histopathological Evaluation to Molecular Testing.Journal of clinical medicine
Tip60-Mediated USP22 Lactylation Drives Glutamine Metabolic Reprogramming via SLC25A5 in TNBC.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ReviewPrecision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC-ICI combinations, and global real-world integration.Frontiers in immunology
Sinapaldehyde Induces Mitochondrial Dysfunction and Modulates Autophagy/Mitophagy-Associated Signaling and Apoptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells.International journal of molecular sciences
Natural ent-kaurene diterpenoid eriocalyxin B suppresses triple negative breast cancer metastasis via modulation of Smad4 SUMOylation and TGF-β signaling pathway.European journal of pharmacology
Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes.Journal of clinical medicine
Cascade DNA walker-driven photo-controlled CRISPR/Cas12a nanorobot enabling ultrasensitive one-pot detection of dual miRNAs in triple-negative breast cancer.Talanta
Identifying barriers to immunotherapy access for triple-negative breast cancer: A qualitative analysis of interviews with medical oncologists.PloS one
Preclinical modeling of trastuzumab deruxtecan in a mouse model of brain metastatic triple-negative breast cancer identifies two contributors to efficacy.Molecular cancer therapeutics
Validating FR20 and D-FR20 for Bromodomain and Extra-Terminal Domain Inhibitor Resistance in Triple-Negative Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Sacituzumab tirumotecan versus chemotherapy in previously treated locally recurrent or metastatic triple-negative breast cancer: final overall survival analysis of the Phase III OptiTROP-Breast01.Annals of oncology : official journal of the European Society for Medical Oncology
Cardiotoxicity of Immune Checkpoint Inhibitors with Anthracycline Chemotherapy in Triple-Negative Breast Cancer.Current oncology (Toronto, Ont.)
Tumor digital twins uncover therapeutic strategies in triple-negative breast cancer.Cell reports. Medicine
Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice.Breast cancer research and treatment
Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study.Diseases (Basel, Switzerland)
LncRNA BCAR4 promotes tumorigenesis in triple-negative breast cancer by stabilizing the MYC-WDR5 complex.Acta biochimica et biophysica Sinica
ReviewCopper complexes in the triple-negative breast cancer landscape: advances and opportunities.Frontiers in molecular biosciences
ZMIZ2-DUX4-LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple-Negative Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Case reportDurable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case report.Frontiers in oncology
Nicotinate Phosphoribosyltransferase controls aggressiveness, Ca2+ homeostasis, and NAD+-derived Ca2+ mobilizing second messengers in triple-negative breast cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Targeting ERO1α triggers tumor immunosurveillance in triple-negative breast cancer.Redox biology
RAB7A-enriched extracellular vesicles drive early-metastasis and immune evasion in triple-negative breast cancer.International journal of biological sciences
Mitochondria-Targeted Prodrug Nanoassemblies Elicit Antitumor Immunity via Mitophagy-Boosted Ferroptosis in Triple-Negative Breast Cancer.Journal of medicinal chemistry
Age-related survival gaps in triple-negative breast cancer: a 10-year real-world analysis.Aging clinical and experimental research
Direct S,S Coordination Suppresses Pt(II)-Thiol Reactivity to Mitigate Nephrotoxicity and Enable Chemo-Photodynamic Therapy against Metastatic Triple-Negative Breast Cancer.Journal of medicinal chemistry
Discovery of Dual PARP/GPX4 Inhibitors for the Treatment of Triple-Negative Breast Cancer.Journal of medicinal chemistry
Large Language Model Framework for Structured Biomarker Extraction and Triple-Negative Breast Cancer Identification From Pathology Reports: Development and Evaluation Study.JMIR formative research
Single-cell and multi-algorithm profiling identifies SNRPG as a Claudin-1-associated regulator of malignant progression in triple-negative breast cancer.Biochimica et biophysica acta. Molecular basis of disease
Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy.ACS nano